Targeting MET in EGFR resistance in non-small-cell lung cancer-ready for daily practice?

Schmid, Sabine; Früh, Martin; Peters, Solange

Schmid, Sabine; Früh, Martin; Peters, Solange.

Afiliação

Schmid S; Department of Oncology and Hematology, Cantonal Hospital St Gallen, St Gallen, Switzerland; Department of Medical Oncology Lung Unit, Princess Margaret Cancer Centre, Toronto, ON, Canada.
Früh M; Department of Oncology and Hematology, Cantonal Hospital St Gallen, St Gallen, Switzerland; Department of Medical Oncology, University of Berne, Berne, Switzerland.
Peters S; Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne University, CH-1011 Lausanne, Switzerland. Electronic address: solange.peters@chuv.ch.

Lancet Oncol ; 21(3): 320-322, 2020 03.

Article em En | MEDLINE | ID: mdl-32027845

Assuntos

Carcinoma Pulmonar de Células não Pequenas; Neoplasias Pulmonares; Acrilamidas; Compostos de Anilina; Receptores ErbB/genética; Humanos; Mutação; Inibidores de Proteínas Quinases; Pirazinas; Triazinas

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google